Failure of oral nitrate and calcium channel blocker therapy to prevent 5-fluorouracil-related myocardial ischemia: a case report

被引:20
作者
Akpek, G
Hartshorn, KL
机构
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
[2] Boston Med Ctr, Dept Med, Hematol Oncol Sect, Boston, MA USA
关键词
5-fluorouracil; cardiac; ischemia; anal carcinoma;
D O I
10.1007/s002800050877
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Myocardial ischemia induced by 5-fluorouracil (5-FU) is a relatively rare, but potentially serious, occurrence. Some case reports have indicated that recurrent ischemia may be prevented if 5-FU is resumed after pretreatment with antianginal therapy. Methods: A 54-year old woman was diagnosed with stage IIA squamous cell carcinoma of the anus. Treatment with concurrent radiation and chemotherapy (mitomycin-C and 5-FU) was initiated with curative intent. Results: The patient had no evidence of underlying coronary artery disease based on history, physical examination or ECG. Approximately 48 h after initiation of 5-FU infusion the patient developed anginal pain associated with ECG changes compatible with ischemia. After resolution of ischemia and ruling out of myocardial infarction, coronary arteriography demonstrated normal coronary arteries. In an attempt to prevent myocardial ischemia, calcium channel blocker and nitrate therapy was started, but anginal pain with ECG change recurred when 5-FU was resumed. This necessitated selection of an alternative chemotherapy regimen. Conclusions: Even in the presence of normal coronary arteries, antianginal therapy may not preclude the occurrence of potentially serious 5-FU induced myocardial ischemia. For patients who experience 5-FU-induced myocardial ischemia, development of alternative chemotherapy regimens should be considered.
引用
收藏
页码:157 / 161
页数:5
相关论文
共 20 条
[1]   Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European organization for research and treatment of cancer radiotherapy and gastrointestinal cooperative groups [J].
Bartelink, H ;
Roelofsen, F ;
Eschwege, F ;
Rougier, P ;
Bosset, JF ;
Gonzalez, DG ;
Peiffert, D ;
vanGlabbeke, M ;
Pierart, M .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) :2040-2049
[2]   5-FLUOROURACIL-INDUCED CORONARY VASOSPASM [J].
BURGER, AJ ;
MANNINO, S .
AMERICAN HEART JOURNAL, 1987, 114 (02) :433-436
[3]   Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: Results in 35 consecutive patients [J].
Doci, R ;
Zucali, R ;
LaMonica, G ;
Meroni, E ;
Kenda, R ;
Eboli, M ;
Lozza, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (12) :3121-3125
[4]   Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study [J].
Flam, M ;
John, M ;
Pajak, TF ;
Petrelli, N ;
Myerson, R ;
Doggett, S ;
Quivey, J ;
Rotman, M ;
Kerman, H ;
Coia, L ;
Murray, K .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (09) :2527-2539
[5]   CLINICAL CARDIOTOXICITY OF 5-FLUOROURACIL [J].
KEEFE, DL ;
ROISTACHER, N ;
PIERRI, MK .
JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (11) :1060-1070
[6]   A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER [J].
KLASTERSKY, J ;
SCULIER, JP ;
RIES, F ;
DABOUIS, G ;
LIBERT, P ;
SCHMERBER, J ;
THIRIAUX, J ;
BERCHIER, MC ;
BUREAU, G ;
VANCUTSEM, O ;
TAGNON, A ;
SERGYSELS, R ;
MOMMEN, P ;
PAESMANS, M .
LUNG CANCER, 1994, 11 (5-6) :373-384
[7]  
KLEIMEN NS, 1987, AM J MED, V82, P556
[8]   CARDIAC TOXICITY OF 5-FLUOROURACIL - A STUDY ON 1083 PATIENTS [J].
LABIANCA, R ;
BERETTA, G ;
CLERICI, M ;
FRASCHINI, P ;
LUPORINI, G .
TUMORI, 1982, 68 (06) :505-510
[9]   TOXIC CARDIOGENIC-SHOCK ASSOCIATED WITH INFUSION OF 5-FLUOROURACIL [J].
MCKENDALL, GR ;
SHURMAN, A ;
ANAMUR, M ;
MOST, AS .
AMERICAN HEART JOURNAL, 1989, 118 (01) :184-186
[10]  
MOSSERI M, 1993, CANCER RES, V53, P3028